MUMBAI - Mumbai-headquartered Calibre Chemicals (Calibre), a nutrition, pharmaceuticals and personal care specialty chemicals company, has entered into a definitive agreement to acquire 100% shareholding of RheinPerChemie GmbH (RPC), from Evonik, a globally leading specialty chemical company. RPC, located in Rheinfelden Germany, is a prominent manufacturer of ammonium and sodium persulphates in Europe.
Calibre is one of the largest manufacturer of potassium persulphate, perchlorates and iodine derivatives in India and serves customers in over 100 countries. With this acquisition, Calibre will become a global, full range persulphates supplier while expanding onshore presence in the European market.
On closure, Calibre would be a front runner for Indian specialty chemical companies investing in green electrochemical opportunities in the western world.
Calibre's CEO, Deepak Chander, said, "We are excited about the cultural and geographical diversity in our functional teams. The RPC acquisition will accelerate organization learning to provide best-in-class products and services to customers and enhance customer centricity for all our business lines in Europe. Teams across the two continents would work together to expand our electrochemistry capability and capacities to further improve existing products and manufacture new products as well."
Calibre and RheinPerChemie's offerings are complementary and revenue accrediting. Calibre has plans to further strengthen manufacturing at RPC and will also add new persulphates capacity in other geographies.
Calibre, an Everstone Capital controlled portfolio joint venture with the Founder, Ranjit Bhavnani's family, is a specialty chemicals company servicing several diverse markets including nutrition, pharmaceuticals, personal & consumer care, industrials and aerospace. Calibre is one of India's largest persulphates, perchlorate and iodine derivatives manufacturer. The company has well-entrenched customer relationships globally and has a leadership position in green electrochemical technology. The Company demonstrably follows high standards of environment, health, safety and regulatory compliances.
About Everstone Capital
Singapore headquartered Everstone Capital, the private equity arm of the Everstone Group, is a global firm committed to driving economic growth and creating sustainable value. With seven offices globally (Singapore, Mumbai, Delhi, Bengaluru, New York, Dubai and Mauritius), Everstone Capital focuses on the mid-market with control mindset and growth bias; comprising best of breed investing, operations and strategic resources with significant experience and skills.
Air Products to Start Construction of Second Liquid Hydrogen Plant in Rotterdam, The Netherlands
New plant brings additional liquid hydrogen capacity to Europe. Once operational in 2025, the plant will double Europe’s total current liquid hydrogen capacity.
ADM Opens New Extrusion Facility in Serbia, Meeting Accelerated Demand for Textured Soy Proteins
The new facility increases ADM’s extrusion capacity in the European region. As an extension of its non-GMO solutions, ADM will now offer both origination and extrusion capabilities of non-GMO soy p...
Mura Technology and Dow plan to locate Europe’s largest advanced recycling facility at Dow’s site in Böhlen, Germany
Mura plans to construct a new facility at Dow’s Böhlen site in Germany – the latest in a series of planned facilities across the U.S. and Europe to rapidly scale advanced recycling of plastics – a...
Merck Invests More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
Increases manufacturing capacity for the Mobius® single-use portfolio. Creates more than 800 jobs by the end of 2028. Investment further strengthens Merck's "Big 3," the key drivers for increasing ...